ANTENGENE CORPORATIO

6996
End-of-day quote. End-of-day quote  - 07/23
16.9HKD 0.00%
Prev.16.9000
Open16.9000
High17.2600
Low16.5400
Volume721 000
Latest news
2d ago
07/13
07/05
07/06
Chart ANTENGENE CORPORATION LIMITED
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralNeutral
Resistance19,921,820,4
Spread/Res.-15%-22%-17%
Spread/Supp.5,0%13%7,9%
Support16,114,915,7
Financials
Sales 2021 2,00 M 0,31 M 0,31 M
Net income 2021 -738 M -114 M -114 M
Net cash 2021 3 342 M 516 M 516 M
P/E ratio 2021 -12,1x
Yield 2021 -
Capitalization 9 462 M 1 460 M 1 460 M
EV / Sales 2021 3 060x
EV / Sales 2022 38,7x
Nbr of Employees 114
Free-Float 56,2%
Company
Antengene Corporation Limited is a clinical-stage Asia-Pacific biopharmaceutical company focused on innovative oncology medicines. The Company is principally engaged in the discovery, development, manufacturing and commercialization of biotech products. The Company’s products include ATG-010...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
No events available
Trading Rating :
Investor Rating : -

Income Statement Evolution
Consensus
Mean consensus BUY
Number of Analysts 5
Last Close Price 14,10 CNY
Average target price 22,86 CNY
Spread / Average Target 62,1%